Based on the criteria listed in Fig. 2a, we analysed 23 MPNST patients and subdivided them into high- (n = 14, 61%) and low-expression PRRX1 groups (n = 9, 39%) (Fig. 2b). The gene discussed is PRRX1; the disease is malignant peripheral nerve sheath tumor.